Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Edwards Lifesciences (EW) PT Raised to $136 at Jefferies Following Investor Day
December 8, 2017 6:50 AM ESTJefferies raised its price target on Edwards Lifesciences (NYSE: EW) to $136.00 (from $132.00) while maintaining a Buy rating.
Analyst Raj Denhoy highlighted three conclusions from EWs annual investor briefing:
1. With efforts to tap less sick, undiagnosed, and untreated populations along with continued... More
Edwards Lifesciences (EW) PT Raised to $135 at Cowen
December 8, 2017 6:40 AM ESTCowen raised its price target on Edwards Lifesciences (NYSE: EW) to $135.00 (from $130.00) while maintaining a Outperform rating.
Analyst Joshua Jennings said EW's 2018 targets are likely conservative and were well received. Jennings said the update to the WW TAVR franchise leaves room for 2018 upside and... More
